Elamipretide, a cardiolipin-targeting peptide, decreases mitochondrial oxidant stress in the failing human heart

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Rapid Fire 5 - Diagnosis - Pathophysiology - Prognosis Pathophysiology HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

ESC 365 is supported by

ESC 365 is supported by